Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Natalie Williams-Bouyer is active.

Publication


Featured researches published by Natalie Williams-Bouyer.


Journal of Clinical Microbiology | 2004

Pulsed-Field Gel Electrophoresis Study of Mycobacterium abscessus Isolates Previously Affected by DNA Degradation

Yansheng Zhang; Mitchell A. Yakrus; Edward A. Graviss; Natalie Williams-Bouyer; Christine Turenne; Amin Kabani; Richard J. Wallace

ABSTRACT DNA degradation (which results in a smear pattern) occurs with almost 50% of Mycobacterium abscessus strains during pulsed-field gel electrophoresis (PFGE). We assessed the potential benefit of using thiourea-containing buffer with M. abscessus by studying 69 isolates not previously typeable by PFGE (i.e., those with a smear pattern). Random (epidemiologically unrelated) isolates that were typeable (no smear pattern) were included as controls. Genomic DNA was digested with DraI, XbaI, and AseI. PFGE gels were run in regular gel buffer with and without 100 μM thiourea. All 69 isolates that generated smear patterns had clear band profiles when the thiourea buffer was used. These isolates were divided into only 30 patterns with DraI, 20 patterns with XbaI, and 20 patterns with AseI. The molecular profiles were all closely or possibly related, and the differences between the isolates ranged from zero to six bands. By multilocus enzyme electrophoresis (MEE), 45 of 53 smear isolates (85%) belonged to two closely related electrophoretic types. These isolates contained at least one enzyme allele seen almost exclusively in this group. Isolates without smear patterns were unaffected by thiourea and produced unrelated PFGE profiles, as well as multiple MEE types. The hsp65 and 16S rRNA gene sequences of the isolates with smear patterns were identical to those of M. abscessus type strain ATCC 19977, which had a nonsmear pattern, suggesting that this clone is a subgroup within M. abscessus. This demonstrates that the inability to type M. abscessus by PFGE is associated with a single clone of organisms.


Clinical Infectious Diseases | 2002

Mycobacterium simiae Pseudo-outbreak Resulting from a Contaminated Hospital Water Supply in Houston, Texas

Hana M. El Sahly; Edward Septimus; Hanna Soini; Joshua Septimus; Richard J. Wallace; Xi Pan; Natalie Williams-Bouyer; James M. Musser; Edward A. Graviss

Various species of nontuberculous mycobacteria are known to cause nosocomial pseudo-outbreaks, but there have been no detailed reports of nosocomial Mycobacterium simiae pseudo-outbreaks. From April 1997 through February 2001, we recovered 65 M. simiae isolates from 62 patients at a community teaching hospital in Houston, Texas. The organism was grown in various water samples obtained in the hospital building and in professional building 1 but not in professional building 2, which has a separate water supply system. Thirty-one environmental and human outbreak-related M. simiae isolates had indistinguishable or closely related patterns on pulsed-field gel electrophoresis and were considered clonal. M. simiae can be a cause of nosocomial pseudo-outbreaks. The reservoir for this pseudo-outbreak was identified as a contaminated hospital water supply.


Journal of Clinical Microbiology | 2001

Clinical Evaluation of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for Rapid Detection of Mycobacterium tuberculosis in Select Nonrespiratory Specimens

Gail L. Woods; John S. Bergmann; Natalie Williams-Bouyer

ABSTRACT The performance of the Amplified Mycobacterium Tuberculosis Direct Test (MTD; Gen-Probe, Inc., San Diego, Calif.) for rapid diagnosis of extrapulmonary tuberculosis was evaluated by testing 178 nonrespiratory specimens from 158 patients. Criteria for specimen inclusion were (i) a positive smear for acid-fast bacilli (n = 54) and (ii) the source if the smear was negative (tissue biopsies and aspirates and abscess material were tested; n = 124). Results were compared to those of mycobacterial culture; clinical history was reviewed when MTD and culture results disagreed. Forty-eight specimens (27.0%) were positive for mycobacteria, including 23Mycobacterium tuberculosis complex specimens; of which 21 were smear positive. Twenty-five specimens were MTD positive; 20 of these grew M. tuberculosis complex. All of the five MTD-positive, M. tuberculosis complex culture-negative specimens were considered truly positive, based on review of the medical record. Of the three MTD-negative, M. tuberculosiscomplex culture-positive specimens, two contained inhibitory substances; one of the two was smear positive. Excluding the latter specimen from analysis, after chart review, the sensitivity, specificity, and positive and negative predictive values of the MTD were 92.6, 100, 100, and 98.7%, respectively, by specimen and 89.5, 100, 100, and 98.6% by patient. Given the few smear-negative samples from patients with extrapulmonary tuberculosis in our study, additional similar studies that include more smear-negative, M. tuberculosis complex culture-positive specimens to confirm our data are desirable.


Journal of Clinical Microbiology | 2003

Multisite Reproducibility of Results Obtained by Two Broth Dilution Methods for Susceptibility Testing of Mycobacterium avium Complex

Gail L. Woods; Natalie Williams-Bouyer; Richard J. Wallace; Barbara A. Brown-Elliott; Frank G. Witebsky; Patricia S. Conville; Marianne Plaunt; Geraldine S. Hall; Priscilla Aralar; Clark B. Inderlied

ABSTRACT A multicenter study was conducted to assess the interlaboratory reproducibility of susceptibility testing of Mycobacterium avium complex (MAC) by broth microdilution using two different media (cation-adjusted Mueller-Hinton broth with 5% oleic acid-albumin-dextrose-catalase and 7H9 broth with casein) and by macrodilution using the BACTEC 460TB and 12B media at pH 6.8 and 7.3 to 7.4. Ten well-characterized strains of MAC (four macrolide susceptible, six macrolide resistant) were tested against clarithromycin and azithromycin (the latter only by BACTEC 460TB, pH 6.8). At each site, strains were tested against clarithromycin three times on each of three separate days (nine testing events per isolate) by using a common lot of microdilution trays and BACTEC 12B medium, pH 6.8; strains were tested once on three separate days against clarithromycin in 12B medium at pH 7.3 to 7.4 and against azithromycin. Agreement among MICs (i.e., mode ± 1 twofold dilution) was 100% for all strains and both drugs when BACTEC 460TB was used, regardless of the pH of the medium, but varied when microdilution with either medium was used, particularly with susceptible strains. Agreement based on interpretive category, with NCCLS-recommended breakpoints, was 100% for all strains with the BACTEC 460TB method (both drugs and both pH values) and with microdilution using 7H9 broth. With microdilution and Mueller-Hinton broth, agreement by interpretive category was 100% for eight isolates and >90% for two; errors occurred only in laboratories where personnel had minimal experience with this technique. MAC susceptibility testing may be performed by broth macrodilution or microdilution at either pH, with NCCLS-recommended interpretive breakpoints. However, because visual interpretation of broth microdilution end points is subjective, it is more prone to reader error; therefore, this method requires greater expertise than the BACTEC 460TB. Both techniques require appropriate validation and continued documentation of proficiency.


Diagnostic Microbiology and Infectious Disease | 2000

Comparison of Gen-Probe AccuProbe Group B streptococcus culture identification test with conventional culture for the detection of Group B streptococci in broth cultures of vaginal-anorectal specimens from pregnant women<

Natalie Williams-Bouyer; Barbara S. Reisner; Gail L. Woods

The performance of the AccuProbe Group B Streptococcus Culture Identification Test (Gen-Probe Incorporated, San Diego, CA, USA) for the detection of group B streptococci (GBS) directly from LIM broth cultures of vaginal-anorectal swab specimens from pregnant women (two swabs per patient in most cases) was evaluated by comparing results to those of conventional GBS culture. Of 411 specimens analyzed, 82 were positive and 312 were negative for GBS by both methods. After initial testing, the percent agreement was 95.9%. The initial sensitivity, specificity, and positive and negative predictive values for the AccuProbe test were 90.1%, 97.5%, 91.1%, and 97.2%, respectively. Results were discrepant for 17 specimens: eight were GBS positive by probe and negative by culture; nine were negative by probe and positive by culture. To resolve discrepancies, culture plates were re-examined for GBS colonies, AccuProbe testing was repeated on the initial LIM broth cultures, and the second swab (if received) was inoculated to LIM broth for AccuProbe testing after overnight incubation. After discrepant resolution testing, the percent agreement between the two test methods was 97.8%. The final sensitivity, specificity, and positive and negative predictive values for the AccuProbe test were 95.6%, 98.4%, 94.6%, and 98.7%, respectively. These data suggest that the AccuProbe test is a reliable method for detecting GBS in vaginal-anorectal specimens, providing results more rapidly than conventional culture. However, strict adherence to the manufacturers test protocol is necessary to limit technical errors.


Burns | 2010

Systemic Pythium insidiosum in a pediatric burn patient

Dori M. Franco; Judith F. Aronson; Hal K. Hawkins; James J. Gallagher; Leonel Mendoza; Michael R. McGinnis; Natalie Williams-Bouyer

Dori M. Franco *, Judith F. Aronson , Hal K. Hawkins , James J. Gallagher , Leonel Mendoza , Michael R. McGinnis , Natalie Williams-Bouyer f Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States Department of Pathology, Autopsy Division, University of Texas Medical Branch, Galveston, TX, United States Department of Surgery, University of Texas Medical Branch, Galveston, TX, United States Biomedical Laboratory Diagnostics, Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI, United States Department of Pathology, Microbiology Division, University of Texas Medical Branch, Galveston, TX, United States Department of Pathology, Microbiology Division, University of Texas Medical Branch, and Clinical Laboratory Services, Shriners Hospitals for Children, Galveston, TX, United States b u r n s 3 6 ( 2 0 1 0 ) e 6 8 – e 7 1


Journal of Clinical Microbiology | 2015

An Investigation into Laboratory Misidentification of a Bloodstream Klebsiella variicola Infection

Gregory J. Berry; Michael J. Loeffelholz; Natalie Williams-Bouyer

Bloodstream infections represent a major burden on the United States health care system, with the number of cases of severe sepsis exceeding 750,000 per year ([1][1]) and representing 10% of all intensive care unit (ICU) admissions ([2][2]). It has also been shown that patient survival rates


Journal of Clinical Microbiology | 2011

Mycobacterium haemophilum and Histoplasma capsulatum Coinfection in a Renal Transplant Patient

Cecilia G. Clement; Michael J. Loeffelholz; Mahmoud A. Eltorky; Yi-Wei Tang; Natalie Williams-Bouyer

ABSTRACT We report the case of a 22-year-old man who presented with a Mycobacterium haemophilum and Histoplasma capsulatum coinfection occurring 21 years after a living-donor-related renal transplant.


IDCases | 2014

Anaerobiospirillum succiniciproducens sepsis in an autopsy patient: A troublesome diagnostic workup

Jason Koshy; Judith F. Aronson; Bhavani Vishwanath; Natalie Williams-Bouyer

Anaerobiospirillum succiniciproducens is an uncommon yet potentially lethal gram-negative bacterium typically affecting patients with comorbidities. We report a case of A. succiniciproducens infection in an autopsy patient who had hepatitis C and type 2 diabetes and describe the difficulties in the laboratory identification of this pathogen.


International Journal of Tuberculosis and Lung Disease | 2013

Can mycobacterial katG genetic changes in isoniazid-resistant tuberculosis influence human disease features?

Patricio Escalante; R. McKean-Cowdin; Srinivas V. Ramaswamy; Natalie Williams-Bouyer; Larry D. Teeter; Brenda E. Jones; Edward A. Graviss

BACKGROUND Isoniazid-resistant (INHr) Mycobacterium tuberculosis isolates often have katG mutations, and katG is a virulence factor in animal models. It is unclear if katG mutations or other mutations influence the characteristics of human disease. OBJECTIVE To determine if the presence of INHr-conferring mutations were associated with distinct clinical features of tuberculosis (TB). METHODS In a retrospective case-control study, INHr-conferring mutations were determined by DNA sequencing. We examined associations between clinical characteristics in patients with INHr M. tuberculosis (stratified by groups of relevant INHr-conferring mutations, including katG-S315T and inhA-C(-)15T mutations) and pan-susceptible (PS) isolates. RESULTS Twenty-nine INHr TB cases and 50 PS controls were evaluated. Disease characteristics were not statistically different between INHr and PS cases. However, patients infected with non-katG mutants were associated with a higher rate of sputum culture conversion at 1 month after adjustment for relevant covariates (adjusted OR [aOR] 4.4, 95%CI 1.1-23.6, P = 0.04). Patients infected with katG mutants were associated with a higher rate of unilateral disease (aOR 4.7, 95%CI 1.0-34.3, P = 0.05). CONCLUSIONS Most INHr TB cases with non-katG mutations have disease associated with faster response to treatment, and most cases with katG mutants have localized lung involvement.

Collaboration


Dive into the Natalie Williams-Bouyer's collaboration.

Top Co-Authors

Avatar

Edward A. Graviss

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar

Gail L. Woods

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

James J. Gallagher

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Richard J. Wallace

University of Texas Health Science Center at Tyler

View shared research outputs
Top Co-Authors

Avatar

Barbara S. Reisner

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Cynthia Villarreal

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Michael J. Loeffelholz

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Barbara A. Brown-Elliott

University of Texas Health Science Center at Tyler

View shared research outputs
Top Co-Authors

Avatar

Cecilia G. Clement

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

James M. Musser

Houston Methodist Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge